Global Dialysis Market (by Number of Patients, Product & Services, Type, End-User, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)

Global Dialysis Market (by Number of Patients, Product & Services, Type, End-User, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)

Market Insight:

When the kidneys cease working properly, dialysis is used to eliminate waste products and excess fluid from the blood. It frequently entails redirecting blood to a machine for cleaning. Dialysis keeps waste products in the blood from reaching dangerously high levels. In an emergency, it can also remove poisons or medications from the blood.

Factors such as the increasing number of diabetic patients, rising healthcare spending, and increased awareness of kidney disorders and their treatment are likely to fuel overall market growth over the forecasted period. The global dialysis market is expected to reach US$107.96 billion in 2023, growing at a CAGR of 4.80% over the projected period.

Segment Covered:

• By Product and Services: In terms of product & service, the report provides the bifurcation of the market into three segments: Services, Consumables, and Equipment. The services segment held the largest share in the market, whereas, the consumables are expected to be the fastest growing segment with a significant CAGR in the forecasted period owing to an increase in the number of people receiving dialysis treatment due to favorable reimbursement systems, the development of improved products, and improved healthcare infrastructure.
• By Type: On the basis of type, the report offers the segmentation of the global dialysis market into the following: Hemodialysis and Peritoneal Dialysis. The hemodialysis segment held the highest share in the market. The market's expansion is aided by the rise in the incidence of kidney failure and end-stage renal disease (ESRD).
• By End-User: The report further delivers an analysis of the global market based on end-user: In-Center Dialysis and Home Dialysis. The home dialysis segment is expected to be the highest-growing segment with a significant CAGR during the forecasted period. From the safety point of view and owing to the continuous advancement in technology, a paradigm shift towards home dialysis treatments & telehealth is expected to better respond to chronic kidney disease (CKD) patients’ needs in the near and long term.
• By Number of Patients: The report also provides a glimpse of the number of dialysis patients. The population of patients receiving dialysis continues to grow rapidly as a result of an increase in the availability of dialysis, population aging, increased prevalence of hypertension and diabetes mellitus, and toxic environmental exposures. The dialysis patients have been analyzed based on type: Hemodialysis and Peritoneal Dialysis. The dialysis patients have also been segmented based on the region: Asia Pacific, Europe, Middle East & Africa (EMEA), North America, and the Rest of the World. Asia Pacific has the highest number of patients receiving dialysis, followed by the EMEA region.

Geographic Coverage:

According to this report, the global dialysis market can be divided into five regions namely North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The countries covered in North America region are the US, Mexico, and Canada, while Europe includes Germany, The UK, France, Italy, Spain, and Rest of the Europe. Moreover, China, Japan, Australia, India, South Korea, and Rest of the Asia Pacific are included in the Asia Pacific region.

North America held the largest share in the market, owing to the favorable reimbursement scenario, and increasing demand for dialysis in the treatment of chronic and acute renal diseases owing to the dearth of kidney donors. Within North America, the US is leading the market owing to an increasing number of kidney diseases. The US dialysis market is further analyzed based on product and services (Services, Consumables, and Equipment), type (Hemodialysis and peritoneal dialysis), and end-user (In-Center Dialysis and Home Dialysis).

The European dialysis market is further studied based on products and services: Services, Consumables, and Equipment. The services segment held the maximum share of the market whereas consumables held the highest CAGR of the market. Furthermore, the Asia Pacific’s dialysis market has been bifurcated based on the following region: China, Japan, Australia, India, South Korea, and the Rest of the Asia Pacific. China held a dominant share in Asia Pacific’s dialysis market, owing to the rising diabetic population. On the other hand, India is expected to be the fastest-growing region.

Top Impacting Factors:

Growth Drivers

• Increasing Diabetic Population
• Increasing Health Spending
• Increasing Consumption of Alcohol
• Increasing Cases of ESRD

Challenges

• High Treatment Costs
• Stringent Regulations

Trends

• Technological Advancements
• Preference of Dialysis Treatment over Transplant
• Rising Demand for Home Dialysis
• Driver: Increasing Cases of ESRD

Affecting 10% of the global population and responsible for more than a million deaths each year, chronic disease has become a major public health issue. ESRD (end-stage renal failure) is the last stage of chronic renal failure. In ESRD, the kidney does not work and requires dialysis to filter wastes and excess fluid from the body. The incidence and prevalence of end-stage renal disease treated by dialysis have increased significantly. The aging population, diabetic population, and high blood pressure are the main reasons for the increasing incidences of ESRD. This trend indicates a growing need for dialysis and kidney transplant to meet the health needs of people with end-stage renal disease. The number of people with diabetes is increasing in developing countries of APAC and Latin America owing to changes in lifestyle. This shows an increasing need for dialysis and kidney transplantation to meet the health needs of individuals with ESRD and thus, driving the dialysis market.

• Challenge: Stringent Regulations

Strict laws and regulations introduced by regulatory authorities are one of the main problems faced by healthcare companies. The development, manufacturing, and marketing of therapeutic devices and pharmaceuticals are subject to numerous regulations from various government agencies around the world. These regulatory requirements vary from country to country. The approval process may be more or less strict from one country to another and the time required for approval may also vary from country to country. In addition, the development and approval of a pharmaceutical product require a significant number of years of operation and significant resource expenditures. They are often subject to unforeseen delays and may be subject to new laws or regulations. Legislation is introduced from time to time, which can significantly change drug approval, production, pricing, and marketing laws. Therefore, the various regulations presents a further hurdle for the dialysis market.

• Trend: Preference of Dialysis Treatment over Transplant

Some of the problem associated with kidney transplant includes donor match, severe surgery, and lifelong immunosuppressive therapy required for a kidney transplant and to prevent rejection. Other than this, there is an acute shortage of donor organs in patients with end-stage renal disease. There are more than 100,000 patients with end-stage renal disease on the waiting list for a transplant in the US. The need for a donor's kidney is increasing by 8% per year, but their availability has not increased to match the demand. Moreover, the transplanted living kidney is considered by the body as a foreign object. Therefore, the patient must take an immunosuppressant for the duration of the transplant. These medications can have many side effects. Because immunosuppressants block the immune system, the transplant recipient is at greater risk of infection and cancer. Therefore, owing to these factors, the preference for dialysis over transplantation has been increasing, which is expected to drive market growth in the coming years.

The COVID-19 Analysis:

COVID-19 has had a positive impact on the growth of the dialysis market as patients are required to continue with their dialysis schedule amid of pandemic also. Moreover, the gradual shift towards home hemodialysis treatment before the pandemic and the concerns over the spread of COVID-19 infection have considerably accelerated patient interest in home hemodialysis treatment. Also, technological advancement during the pandemic has boosted the market and is expected to continue to do so in the coming years. For instance, starting in 2021, customers have benefited from the virtual reality (VR) tool, staysafe MyTraining VR (launched by Fresenius Medical Care), to support patient training for continuous ambulatory peritoneal dialysis (CAPD).

Analysis of Key Players:

The global dialysis market is consolidated. The key players in the global dialysis market are:

• Becton, Dickinson and Company (C.R. Bard, Inc.)
• Fresenius Medical Care AG & Co. KGaA
• Medtronic Plc
• Nipro Corporation
• Baxter International, Inc.
• B. Braun (B. Braun Avitum AG)
• Nikkiso Co. Ltd.
• Toray Industries, Inc.
• DaVita Inc.
• Quanta Dialysis Technologies Ltd.
• Diaverum
• Asahi Kasei Corporation
• AngioDynamics, Inc.

Some of the strategies among key players in the market are product launches, mergers, acquisitions, and collaborations. For instance, in 2022, DaVita Inc. and Medtronic plc announced the intent to form a new, independent kidney care-focused medical device company (NewCo) to enhance the patient treatment experience and improve overall outcomes. Whereas, Baxter International Inc. announced the US Food and Drug Administration (FDA) 510(k) clearance of the company’s ST Set used in continuous renal replacement therapy (CRRT).